Pamela Bonnett

Pamela Bonnett is the current CEO at Ultrasound AI Inc. Pamela has over 20 years of experience in sales and marketing and has held various executive positions at different companies.

Bonnett started their career as a senior sales executive at Healthgate Data Corp in 2001. In this role, they were responsible for increasing sales and developing new business opportunities. After a year in this role, they left to start their own consulting firm, Bonnett Consulting LLC.

In 2018, Bonnett joined KaVo Kerr as the Vice President of North America, Commercial. In this role, they were responsible for leading the field and inside sales teams, as well as the customer support, marketing, and commercial operations teams. Bonnett was also responsible for site leadership at the Yorba Linda, CA and Mahwah, NJ locations.

In October 2019, Bonnett left KaVo Kerr to join Nobel Biocare as the Vice President of North America. Bonnett was enlisted to help stabilize the business and increase growth. During their time at Nobel Biocare, they successfully stabilized the business with 0% turnover by January 2020 and delivered growth in December 2020.

In April 2021, Bonnett left Nobel Biocare to become the CEO at Ultrasound AI Inc.

Pamela Bonnett has an ongoing education in the field of Change Acceleration Process (CAP) and is Six Sigma Green Belt Certified. Pamela has also taken courses in Coaching Conversations and Situation from GE Healthcare. In addition, they have completed Executive Education programs in Advanced Manager Development from GE Crotonville. Pamela also has a Bachelor of Science (B.S.) in Marketing from DePaul University.

Some individuals on their team include David Dahn - Chief Financial Officer, Garrett Lam - Chief Medical Officer, and Robert Bunn - President & Founder.